Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7531.098
uM
inf
inf
0.9783 0.9783 0.0000 -0.0040
0.0169
3.4793
HCC1954
HER2amp
Basal A
Nilotinib
ABL
nRTK
11055.145
uM
inf
inf
0.9791 0.9791 0.0000 -0.0257
-0.8188
1.7616
MDA-MB-415
HR+
Luminal
AG1024
IGF1R
RTK
7511.066
uM
inf
inf
0.9792 0.9792 0.0000 -0.0212
-0.3797
1.1691
AU565
HER2amp
Luminal
Purvalanol A
CDK1
CDK
5900.067
uM
inf
inf
0.9793 0.9793 0.0000 -0.0189
-0.4227
2.4324
MDA-MB-361
HER2amp
Luminal
GM6001
MMP
MMP
7506.096
uM
inf
inf
0.9793 0.9793 0.0000 0.0173
-0.0292
1.0303
MDA-MB-134-VI
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7494.098
uM
inf
inf
0.9802 0.9802 0.0000 0.0609
-0.0984
0.9748
AU565
HER2amp
Luminal
Nilotinib
ABL
nRTK
10880.145
uM
inf
inf
0.9804 0.9804 0.0000 0.0621
0.0247
1.4751
AU565
HER2amp
Luminal
PS-1145
IKK
NFKB
5901.065
uM
inf
inf
0.9807 0.9807 0.0000 0.0027
-0.0002
2.0114
HCC1419
HER2amp
Luminal
Cetuximab
EGFR
ErbB
10019.124
uM
inf
inf
0.9810 0.9810 0.0000 -0.0457
-3.7312
0.5356
HCC1187
TNBC
Basal A
AG1478
EGFR
ErbB
7811.044
uM
inf
inf
0.9811 0.9811 0.0000 0.0159
-0.0256
0.3073
HCC1954
HER2amp
Basal A
FTase Inhibitor I
Ftase
MAPK
11055.154
uM
inf
inf
0.9813 0.9813 0.0000 0.0080
-0.0117
1.7768
MB 157
Unknown
Unknown
AS-252424
PI3K
PI3K
12580.165
uM
inf
inf
0.9815 0.9815 0.0000 0.0012
0.1111
2.2883
T47DKBLUC
Unknown
Unknown
FTase Inhibitor I
Ftase
MAPK
12608.167
uM
inf
inf
0.9819 0.9819 0.0000 -0.0030
0.1862
1.2681
MCF 10A
NM
Basal B
Lapatinib
EGFR/HER2
ErbB
7484.098
uM
inf
inf
0.9819 0.9819 0.0000 0.0183
0.3261
2.6137
HCC70
TNBC
Basal A
CPT-11
TOP1
TOP
7860.043
uM
inf
inf
0.9822 0.9822 0.0000 0.0201
0.2254
0.7488
BT-549
TNBC
Basal B
GSK1838705A
IGF1R
RTK
5910.091
uM
inf
inf
0.9825 0.9825 0.0000 0.0118
0.2290
3.3208
HCC1806
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
12239.154
uM
inf
inf
0.9833 0.9833 0.0000 0.0201
0.0190
2.2015
MDA-MB-231
TNBC
Basal B
AG1478
EGFR
ErbB
7892.016
uM
inf
inf
0.9839 0.9839 0.0000 -0.0090
-0.1042
2.3475
CAMA-1
HR+
Luminal
FR180204
ERK1/2
MAPK
10473.137
uM
inf
inf
0.9840 0.9840 0.0000 0.0297
-0.0565
1.1322
BT-20
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
5902.098
uM
inf
inf
0.9860 0.9860 0.0000 -0.0045
-0.0403
1.1137
MCF7
HR+
Luminal
JNK-IN-5A
JNK
JNK
10997.144
uM
inf
inf
0.9861 0.9861 0.0000 0.0703
0.2540
1.2750
SUM149PT
TNBC
Basal B
Nilotinib
ABL
nRTK
10819.145
uM
inf
inf
0.9866 0.9866 0.0000 0.0162
0.0826
2.1971
MDA-MB-361
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9648.026
uM
inf
inf
0.9880 0.9880 0.0000 -0.0302
-1.2808
0.7065
MDA-MB-157
TNBC
Basal B
AG1024
IGF1R
RTK
7498.066
uM
inf
inf
0.9884 0.9884 0.0000 -0.0181
-0.3947
1.0752
BT-474
HER2amp
Luminal
Purvalanol A
CDK1
CDK
5906.067
uM
inf
inf
0.9890 0.9890 0.0000 -0.0331
-0.7588
0.6838